Greenwich Wealth Management’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-13,507
Closed -$362K 175
2015
Q1
$362K Sell
13,507
-11,311
-46% -$319K 0.04% 143
2014
Q4
$728K Sell
24,818
-4,492
-15% -$111K 0.05% 118
2014
Q3
$591K Sell
29,310
-1,295
-4% -$25K 0.04% 128
2014
Q2
$512K Buy
30,605
+2,105
+7% +$29.8K 0.03% 120
2014
Q1
$424K Buy
28,500
+200
+0.7% +$3.08K 0.03% 128
2013
Q4
$414K Buy
28,300
+850
+3% +$13.7K 0.04% 128
2013
Q3
$472K Buy
27,450
+2,950
+12% +$43.8K 0.03% 118
2013
Q2
$284K Buy
+24,500
New +$281K 0.02% 128

Other funds holding AMED

Greenwich Wealth Management's AMED Position: Q2 2015 in Review

Greenwich Wealth Management sold out of Amedisys (AMED) in Q2 2015, closing a stake of 13,507 shares — an estimated $362K sold.

Greenwich Wealth Management first reported a position in AMED in Q2 2013 and held it in 8 quarters. The position peaked at $728K in Q4 2014. 142 funds tracked by Wall St. Rank hold AMED as of Q2 2015.

  • Greenwich Wealth Management reported no remaining Amedisys position as of Q2 2015 after selling out during the quarter.
  • Greenwich Wealth Management sold 13,507 Amedisys shares in Q2 2015, an estimated $362K.
  • Greenwich Wealth Management first reported a position in Amedisys in Q2 2013 and held it in 8 quarters.
  • Greenwich Wealth Management's Amedisys position peaked at $728K in Q4 2014.
  • 142 funds tracked by Wall St. Rank held Amedisys as of Q2 2015.

Based on Greenwich Wealth Management's 13F filing for Q2 2015, filed 10 Aug 2015.